CAMs-M2-derived TGF-β1 triggers EMT progression through the TGF-β/Smad2/Snail pathway, and inhibition of the TGF-β/Smad2 pathway by the TGF-β receptor inhibitor suppresses EMT-promoting CRC metastasis [154]. This evidence concerns the gene SMAD2 and colorectal carcinoma.